Episode notes
Featuring Scott Pancoast, Founder and CEO
Zylö Therapeutics, located in Greenville, has developed an innovative sustained-release topical drug delivery system that uses patented xerogel-derived silica particles, called Z-pods™, to sustainably deliver Nitric Oxide, cannabinoids, and other notoriously hard-to-deliver therapeutic agents through topical administration. The game-changing technology enables a Patchless Patch™ concept, which provides long-term delivery to the skin but without the hassles and inconvenience of a patch. Visit company website.
Keywords
zylö therapeuticszylö